Teewinot has assembled a veteran management team with demonstrated success in leadership, growth, pharmaceutical development, marketing, and aftermarket support.
Management has organized a team of highly experienced scientists, business people, attorneys and other support personnel who are carefully aligning the intellectual property strategy with business goals and scientific developments. All scientific developments are carefully screened to determine whether they support Teewinot’s business goals and should be best protected as a trade secret or through the patent process. Freedom to bring new products and processes to market is carefully evaluated on an ongoing basis. The intellectual property strategy is designed to enhance Teewinot’s value by providing market exclusivity, freedom-to-operate, and revenue generating opportunities through licensing and sale of assets.
Michael A. Luther Ph.D., MBA
President & CEO, Teewinot Life Sciences
Michael Luther is the Chief Executive Officer of Teewinot Life Sciences. In this capacity, Mr. Luther is responsible for corporate management, the development and implementation of Teewinot’s strategic plan, and ultimately Teewinot’s financial performance.
C-level executive with 30+ years of extensive expertise in building, implementing, and successfully leading biopharmaceutical companies and operations. Experience from leading virtual start-ups to global pharmaceutical companies including roles in R&D, manufacturing, licensing and drug development. Positions range from large global divisions (CROs and bio-pharmaceutical companies) to board of director roles for public and private companies.
Steve Orndorff Ph.D.
Chief Operating Officer, Teewinot Life Sciences
President & CEO, Canalis Pharmaceuticals Inc.
Business executive, scientist and serial entrepreneur with 30 years of experience in the biotechnology industry in various roles of management, business development, R&D, commercialization and manufacturing. Extensive experience with developing small molecule drugs in a variety of clinical indications including CNS, metabolic and autoimmune diseases, and pharmacogenomic-based drug therapies. Developed and deployed large scale commercial manufacturing of recombinant proteins and complex small molecules for pharmaceutical and consumer end uses. Regulatory experience and success in orphan drug approvals and clinical development.
Jeffrey S. Mathiesen, CPA
Chief Financial Officer, Teewinot Life Sciences
C-level executive with 30+ years of extensive expertise in growth-oriented, technology based, publicly traded companies across a wide variety of industries, including several life sciences companies. Experience in leading the financial, operational, capital attainment and infrastructure development functions of early stage companies through various stages of growth. Background includes several IPOs, M&A transactions and successful exits.
Dr. Malcolm Kavarana
Chief Scientific Officer, Teewinot Life Sciences
Senior Director Intellectual Property, Teewinot Life Sciences
Dr. Kavarana evaluates and establishes recommendations on new scientific opportunities, collaborations, and licensing opportunities, to advance Teewinot’s role as a leader in cannabinoid based therapeutics. Dr. Kavarana also defines project guidelines and research priorities and interfaces with CRO’s, CMO’s and collaborators on aligning the goals of research projects with the overall mission and commercial goals of Teewinot. Malcolm has in depth experience across the entire spectrum of drug development. Malcolm is co-author on over 16 peer-reviewed scientific publications as well as co-inventor on over 25 patents and patent applications.
Eric A. Walker
Chief Information Officer, Teewinot Life Sciences
Eric Walker is a technology veteran of more than 20 years of executive technology focused management experience at AT&T, IBM, IRS and Cisco. He is also responsible for global information technology strategies, marketing and public relations, and corporate policies and procedures. Eric is actively engaged in the global strategic implementation of Teewinot’s branding, social and digital media footprint with overall leadership of the companies corporate security, data storage, and telecommunications technology.